{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:34:41Z","timestamp":1793169281911,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation Project of Jurong People\u2019s Hospital","award":["JY20231005"],"award-info":[{"award-number":["JY20231005"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study aimed to develop and validate an integrated model combining pretreatment hemoglobin, albumin, lymphocyte, platelet (HALP) score and T2-weighted magnetic resonance imaging radiomics for predicting pathological complete response (pCR) and overall survival in patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy. A total of 137 consecutive LARC patients from January 2019 to January 2022 were retrospectively included. Pretreatment 3.0T T2-weighted high-resolution magnetic resonance imaging scans were performed. Four stable features were selected using least absolute shrinkage and selection operator regression. The HALP score was calculated as (hemoglobin\u2005\u00d7\u2005albumin\u2005\u00d7\u2005lymphocytes)\/platelets, with an optimal cutoff of 48.4 determined by X-tile analysis. Three predictive models were constructed: a radiomics-only model (RAD), a HALP-only model (HALP), and a combined model (RAD\u2005+\u2005HALP) using a random forest classifier. Model performance was assessed using the area under the curve (AUC), sensitivity, specificity, calibration curves, and decision curve analysis. The pCR rate was 13.1% (18\/137). For pCR prediction, the combined model achieved an AUC of 0.808 (95% confidence interval: 0.73\u20130.88), compared to 0.788 for the RAD model. The HALP score alone did not show predictive capability (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.59). For overall survival prediction, the combined model significantly outperformed the individual models, with an AUC of 0.957 (sensitivity: 0.945, specificity: 1.0; DeLong test,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002), the AUC was corrected to 0.852 (sensitivity: 0.788, specificity: 0.889;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Multivariate Cox analysis identified HALP as an independent prognostic factor (hazard ratio: 5.83, 95% confidence interval: 2.23\u201315.2). The combined RAD\u2005+\u2005HALP model demonstrated excellent and internally validated performance in predicting both short-term treatment response and long-term survival in LARC patients undergoing neoadjuvant chemoradiotherapy patients. Prospective multicenter studies are warranted prior to clinical application.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050554","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:09:29Z","timestamp":1789142969000},"page":"e50554","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of HALP combined with T2-weighted MRI radiomics in predicting pathological complete response and overall survival in rectal cancer after neoadjuvant chemoradiotherapy"],"prefix":"10.1097","volume":"105","author":[{"given":"Xiaolei","family":"Wan","sequence":"first","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqiang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Coordination, Nanjing Yuzhong Medical Consulting Co., Ltd., Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Coordination, Nanjing Yuzhong Medical Consulting Co., Ltd., Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Di","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0261-975X","authenticated-orcid":false,"given":"Xiaojiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261028","first-page":"177","article-title":"Colorectal cancer statistics, 2017.","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"suppl_4","key":"R2-20261028","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Annal Oncol"},{"key":"R3-20261028","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"key":"R4-20261028","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cncr.30600","article-title":"Total neoadjuvant therapy for rectal cancer: an emerging option.","volume":"123","author":"Ludmir","year":"2017","journal-title":"Cancer"},{"key":"R5-20261028","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00259-018-4250-6","article-title":"Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features.","volume":"46","author":"Giannini","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20261028","first-page":"7","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R7-20261028","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"R8-20261028","doi-asserted-by":"crossref","first-page":"874","DOI":"10.6004\/jnccn.2018.0061","article-title":"Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology.","volume":"16","author":"Benson","year":"2018","journal-title":"J Nat Comprehensive Cancer Network"},{"key":"R9-20261028","doi-asserted-by":"crossref","first-page":"djw171","DOI":"10.1093\/jnci\/djw171","article-title":"Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer.","volume":"108","author":"Martens","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R10-20261028","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00330-018-5683-9","article-title":"Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.","volume":"29","author":"Cui","year":"2019","journal-title":"Eur Radiol"},{"key":"R11-20261028","article-title":"Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: preliminary findings [published online ahead of print February 13, 2018].","author":"Sun","journal-title":"J Magn Reson Imaging"},{"key":"R12-20261028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.211986","article-title":"MRI radiomics model predicts pathologic complete response of rectal cancer following chemoradiotherapy.","volume":"303","author":"Shin","year":"2022","journal-title":"Radiology"},{"key":"R13-20261028","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1007\/s00330-020-06968-6","article-title":"Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.","volume":"30","author":"Shaish","year":"2020","journal-title":"Eur Radiol"},{"key":"R14-20261028","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness.","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"R15-20261028","doi-asserted-by":"crossref","first-page":"72076","DOI":"10.18632\/oncotarget.12271","article-title":"Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer.","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"R16-20261028","doi-asserted-by":"crossref","first-page":"41370","DOI":"10.18632\/oncotarget.5629","article-title":"Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study.","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"R17-20261028","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4049\/jimmunol.1900311","article-title":"IL-11 induces encephalitogenic Th17 cells in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"203","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"key":"R18-20261028","doi-asserted-by":"crossref","first-page":"1138145","DOI":"10.3389\/fimmu.2023.1138145","article-title":"Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.","volume":"14","author":"Tarique","year":"2023","journal-title":"Front Immunol"},{"key":"R19-20261028","doi-asserted-by":"crossref","first-page":"e2221007120","DOI":"10.1073\/pnas.2221007120","article-title":"IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.","volume":"120","author":"Seyedsadr","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20261028","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.4049\/jimmunol.1400620","article-title":"SHP-1 plays a crucial role in CD40 signaling reciprocity.","volume":"193","author":"Khan","year":"2014","journal-title":"J Immunol"},{"key":"R21-20261028","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12894-018-0333-8","article-title":"Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.","volume":"18","author":"Peng","year":"2018","journal-title":"BMC Urol"},{"key":"R22-20261028","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.21037\/jgo-21-507","article-title":"A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer.","volume":"12","author":"Wang","year":"2021","journal-title":"J Gastrointestinal Oncol"},{"key":"R23-20261028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0016.0959","article-title":"Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?","volume":"95","author":"Yordanagil","year":"2022","journal-title":"Polski Przeglad Chirurgiczny"},{"key":"R24-20261028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/jca.27210","article-title":"The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy.","volume":"10","author":"Guo","year":"2019","journal-title":"J Cancer"},{"key":"R25-20261028","doi-asserted-by":"crossref","first-page":"e20126","DOI":"10.1016\/j.heliyon.2023.e20126","article-title":"HALP score based on hemoglobin, albumin, lymphocyte and platelet can predict the prognosis of tongue squamous cell carcinoma patients.","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"R26-20261028","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S2468-1253(19)30056-1","article-title":"Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.","volume":"4","author":"Taylor","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R27-20261028","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiol.2018172300","article-title":"MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy.","volume":"287","author":"Horvat","year":"2018","journal-title":"Radiology"},{"key":"R28-20261028","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis.","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:01:38Z","timestamp":1793167298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050554"}},"subtitle":["A retrospective single-center study in China"],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":28,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050554","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2026-04-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}